Although somatic mutations in BRCA1 gene represent about 40 %, there is a highly dysfunction in BRCA1 within tumor cells by other mechanisms, notably epigenetic modifications like gene methylation [20, 22–24]. This evidence concerns the gene BRCA1 and neoplasm.